(੭*ˊᵕˋ)੭ try Send-An-Email.com send anonymous email free

The FDA Just Approved This New treatment For Metastatic Breast Cancers

Say and pronounce The FDA Just on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

29 (UPI) -- The U.S. Food and Drug Administration Thursday approved Verzenio to treat adult patients with HR-positive and HER2-negative metastatic breast cancer. Verzenio, or abemaciclib, was approved to treat hormone-receptor-positive, or HR-positive, and human-epidermal-growth-factor-receptor 2-negative, or HER2-negative, advanced or metastatic breast cancer that progresses after endocrine therapy. https://www.upi.com/Health_News/2017/... http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com

Tags

Food and Drug Administration breast cancer metastasis Metastatic breast cancer cancer Metastatic Breast Cancer HER 2-Negative Breast Cancer RTT Protein Kinase Inhibitors Ribbon Symbolism Breakthrough Therapy HER 2/Neu Abemaciclib HER2-negative Breast Cancer Verzenio
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  Novartis Metastatic Breast Cancer Treatment   New Way To Zap Cellulite?   Assessing the Use of Bevacizumab   FDA approves expanded uses for immunotherapy   New study suggests that drinking coffee can lower your risk of death   New study suggests that drinking coffee can lower your risk of death   Frontline Treatment of ER-Positive Breast Cancer   New ALS drug treatment   Frontline Therapy in Metastatic Breast Cancer   Treatment of Metastatic Breast Cancer With Taxanes   Clinical Experience: CDK4/6 Inhibitors in Breast Cancer   Health Alert: FDA approves first treatment for sickle cell disease   FDA approves game changing treatment for Multiple Sclerosis   CDK 4/6 Inhibitors in Metastatic Breast Cancer   Treatment With Eribulin in Metastatic Breast Cancer   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   Case Study: Treating Metastatic Triple-Negative Breast Cancer   First-Line ER-Positive Metastatic Breast Cancer Treatments   Dr. Reidy-Lagunes on FDA Approval of Telotristat Epitrate for Carcinoid Syndrome   Everolimus for HR+ Metastatic Breast Cancer   Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC   Norfolk woman told she has breast cancer -- when she doesn't   Health Alert: FDA approves first treatment for leukemia   Pioneering Treatment for Hypoplastic Left Heart Syndrome - Mayo Clinic   Research Shows Effective New Class Of Breast Cancer Drugs Well-Tolerated   Dr. Araujo on Importance of Bone-Targeting Agents in mCRPC   Family fears local boy with rare disease will lose access to breakthrough drug   Video: Cancer patient urges women to get screened   Metastatic Breast Cancer Awareness   Dr. Araujo on Emerging Data on Radium-223 for Patients With mCRPC   Western New Yorkers among first in nation receiving new ALS drugV   Treating knee pain   FDA Approval of Ribociclib for Metastatic Breast Cancer   What Is Colorectal Cancer? | Basavatarakam Indo American Cancer Hospital | Health Time | 10TV   FDA Approves Use of Breast Cancer Treatment Nerlynx   FDA Approvals in Follicular Lymphoma and Prostate Cancer, Biosimilar Is Granted Approval, and More   New Breast Exam Nearly Quadruples Detection of Invasive Breast Cancers in Some Women   FDA endorses groundbreaking cancer treatment   US clears first 'living drug' for tough childhood leukemia   FDA approves new drug for MS treatment   Daytime Metastatic Breast Cancer   Drug Shows Promise As New Treatment For Breast Cancer   New Immunotherapy Approved for Metastatic Bladder Cancer   Cap prevents hair loss during chemo   New Drug for Sickle Cell Disease Approved by FDA   New FDA approved weight loss pill helps decrease appetite   Dr. Chagpar on Novel Agents for Neoadjuvant TNBC Treatment   FDA Panel Recommends New Experimental Leukemia Treatment Be Approved   FDA FDA: Breast implants can cause rare cancer   Exceptional Responders in Breast Cancer   FDA approves 'gene therapy' leukemia treatment   Second-Line Everolimus in Metastatic Breast Cancer   FDA OKs Drug for Multiple Sclerosis   Drug Helps Fight Breast Tumors Tied to 'Cancer Genes'   Dr. Plimack on the Challenges With Available Immunotherapies for Bladder Cancer   Role of Lapatinib in HER2-Positive Breast Cancer   Role of the Multikinase Inhibitor Regorafenib in Metastatic Colorectal Cancer   New Device Automatically Administers Insulin   FDA Approvals in MSI-High Cancers, Priority Reviews in Gastric Cancer and FL, and More   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   New MS drug kicks off in WNY   FDA Approves MM-398, T-VEC, and Trabectedin, New Pembrolizumab Data, and More   Dr. Pal on RCS in Metastatic Urothelial Carcinoma   Future Directions for Metastatic Breast Cancer   Ask the Expert: New Leukemia treatment   Dr. West on FDA Approval of Brigatinib in ALK+ NSCLC   Big Banks and Big Pharma Just Scored A Huge Payday From The Dysfunctional FDA   General Screenings   FDA Approvals in Breast Cancer and Hodgkin Lymphoma, 2017 SGO Highlights, and More   Dr. Kornblum on Results of PrECOG 0102 in Breast Cancer   Some small tumors in the breasts: can not be so bad after all.   CDK4/6 Inhibitors in Metastatic Breast Cancer   HER2 Testing in Metastatic Breast Cancer   Dr. Kornblum on PrECOG 0102 in Breast Cancer   What's next in fighting cancer with polio virus?

Popular Today